<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Geriatr Soc</journal-id><journal-id journal-id-type="iso-abbrev">J Am Geriatr Soc</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of the American Geriatrics Society</journal-title></journal-title-group><issn pub-type="ppub">0002-8614</issn><issn pub-type="epub">1532-5415</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11908922</article-id><article-id pub-id-type="pmcid-ver">PMC11908922.1</article-id><article-id pub-id-type="pmcaid">11908922</article-id><article-id pub-id-type="pmcaiid">11908922</article-id><article-id pub-id-type="manuscript-id">NIHMS2037490</article-id><article-id pub-id-type="pmid">39618093</article-id><article-id pub-id-type="doi">10.1111/jgs.19290</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2037490</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2037490</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Rates and Predictors of Opioid Deprescribing after Fracture: A Retrospective Study of Medicare Fee-for-Service Claims</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Pritchard</surname><given-names initials="KT">Kevin T.</given-names></name><degrees>OT, PhD, OTR</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="CT">Chun-Ting</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="Q">Qiaoxi</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="Y">Yichi</given-names></name><degrees>MS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wilkins</surname><given-names initials="JM">James M.</given-names></name><degrees>MD, DPhil</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="DH">Dae Hyun</given-names></name><degrees>MD, MPH ScD</degrees><xref rid="FN1" ref-type="author-notes">*</xref><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lin</surname><given-names initials="KJ">Kueiyu Joshua</given-names></name><degrees>MD, MPH, ScD</degrees><xref rid="FN1" ref-type="author-notes">*</xref><xref rid="A1" ref-type="aff">1</xref><xref rid="A5" ref-type="aff">5</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women&#8217;s Hospital, Harvard Medical School, Boston, MA, USA</aff><aff id="A2"><label>2</label>Division of Geriatric Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA, USA</aff><aff id="A3"><label>3</label>Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA</aff><aff id="A4"><label>4</label>Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Massachusetts, USA</aff><aff id="A5"><label>5</label>Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA</aff><author-notes><fn fn-type="equal" id="FN1"><label>*</label><p id="P1">D.H.K. and K.J.L. contributed to the work equally.</p></fn><fn fn-type="con" id="FN2"><p id="P2">Author Contributions:</p><p id="P3"><bold><italic toggle="yes">Concept and design:</italic></bold> All authors</p><p id="P4"><bold><italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic></bold> All authors</p><p id="P5"><bold><italic toggle="yes">Drafting of the manuscript:</italic></bold> Pritchard</p><p id="P6"><bold><italic toggle="yes">Critical revision of the manuscript for important intellectual content:</italic></bold> All authors</p><p id="P7"><bold><italic toggle="yes">Statistical analysis:</italic></bold> Pritchard, Yang, Zhang</p><p id="P8"><bold><italic toggle="yes">Obtained funding:</italic></bold> Lin, Kim</p><p id="P9"><bold><italic toggle="yes">Supervision</italic>:</bold> Lin</p></fn><corresp id="CR1"><bold>Corresponding Author:</bold> Kueiyu Joshua Lin, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women&#8217;s Hospital, Harvard Medical School, 1620 Tremont St. Suite 3030, Boston, MA 02120, <email>kpritchard3@bwh.harvard.edu</email>, <email>jklin@bwh.harvard.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>01</day><month>12</month><year>2024</year></pub-date><volume>73</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">484261</issue-id><fpage>737</fpage><lpage>749</lpage><pub-history><event event-type="nihms-submitted"><date><day>29</day><month>01</month><year>2025</year></date></event><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-15 16:25:31.647"><day>15</day><month>03</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2037490.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P10">Adults with Alzheimer&#8217;s Disease and Alzheimer&#8217;s Disease Related Dementias (ADRD) or frailty are susceptible to fractures. Opioid analgesics are frequently prescribed after fractures. Documenting post-fracture opioid discontinuation rates and predictors of discontinuation among adults with ADRD or frailty can inform clinical practice, identify potential disparities, and improve pain management guidelines. The objective of this paper was to investigate opioid discontinuation in opioid-na&#239;ve older adults who used opioids after an acute fracture.</p></sec><sec id="S2"><title>Methods:</title><p id="P11">This retrospective cohort study included opioid-na&#239;ve Medicare fee-for-service beneficiaries (N=33,027) &#8805; 65 years of age who filled an opioid prescription within 30 days of a vertebral, lower extremity, or upper extremity fracture from 2013&#8211;2018. Beneficiaries were classified according to ADRD (yes/no) and frailty (yes/no) status using validated claims-based algorithms. The primary outcome was opioid discontinuation, defined as a 30-day supply gap. We estimated discontinuation rates with the Kaplan-Meier method and identified predictors of opioid discontinuation using Cox proportional hazards regression.</p></sec><sec id="S3"><title>Results:</title><p id="P12">The 30-day opioid discontinuation rate was similar among non-frail beneficiaries without ADRD (81% [95% CI, 80&#8211;81%]) and those who were non-frail with ADRD (83% [81&#8211;84%]). Comparatively, 30-day discontinuation rates were lower among those with frailty and ADRD (76% [75&#8211;77%]) and those with frailty alone (77% [75&#8211;78%]). After adjusting for sociodemographic characteristics, health status, healthcare utilization, and calendar year, beneficiaries with both ADRD and frailty (HR, 0.90 [0.87&#8211;0.93]) and those with frailty alone (HR, 0.85 [0.82&#8211;0.89]), but not those with ADRD alone (HR, 1.06 [1.01&#8211;1.10]), were less likely to discontinue opioids compared with those without ADRD or frailty.</p></sec><sec id="S4"><title>Conclusions and Relevance:</title><p id="P13">Our findings suggest that frailty, but not ADRD, was associated with a lower likelihood of opioid discontinuation among older adults who initiated opioids after an acute fracture. Further research is needed to understand how opioid deprescribing practices depend on patient and provider preferences.</p></sec></abstract><kwd-group><kwd>(<italic toggle="yes">MeSH</italic>)</kwd><kwd>Dementia</kwd><kwd>Fracture</kwd><kwd>Medicare</kwd><kwd>Opioid</kwd><kwd>Pain</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>